ACTIVE

GD MEDICAL BELGIUM

Financial year 2025 · Closed on 31/12/2025

Net result48,6 k €-44,4 %over 1 year
Gross margin927 k €+10,0 %over 1 year
Equity225,3 k €+27,5 %over 1 year
Workforce5,0 ETP+25,0 %over 1 year

Identity

Source · BCE/KBO

GD MEDICAL BELGIUM is a Private limited company incorporated in 2019. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Etterbeek. It employs on average 5,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0734.616.929
Incorporation
18/09/2019
Legal form
Private limited company
Registered office
Rue Abbé Cuypers 3
1040 Etterbeek · BruxellesSee on map
Contributed capital
1,00 €
Latest accounts
31/12/2025
Average workforce
5,0 ETP
Joint committees (1)
  • 200
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 6 filings

Trend over 6 financial years

20252024202320222021
Income statement
Gross margin927 k €843 k €602,3 k €601,1 k €549,7 k €
EBITDA221,4 k €277,1 k €75,6 k €149,4 k €118,1 k €
Operating result112,8 k €165,6 k €19,5 k €110,3 k €77,7 k €
Net result48,6 k €87,5 k €-10,4 k €56,2 k €36,3 k €
Balance sheet
Equity225,3 k €176,7 k €89,2 k €99,7 k €43,5 k €
Total assets1,1 M €1,3 M €1,2 M €801,5 k €760,6 k €
Cash82,4 k €133,6 k €7,7 k €21,8 k €74,5 k €
Debts855,4 k €1,1 M €1,1 M €652,8 k €673,5 k €
Other
Workforce5,0 ETP4,0 ETP3,8 ETP3,8 ETP4,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

CLV Holding BV

Director · since 21 décembre 2022

Represented by Roel Eduard Jacques Claassen

Active
Geert Vanwalleghem

Director · since 25 septembre 2019

Active

Ended mandates

Marinus Verhofstadt

Director · since 25 novembre 2021 · until 04 mars 2024

Ended
Marinus Verhofstadt

Director · since 25 novembre 2021

Ended
RM Invest BV

Director · until 21 décembre 2022

Represented by Roel Eduard Jacques Claasen

Ended
RM Invest BV

Director

Represented by Roel Eduard Jacques Claasen

Ended

Other companies at this address

Rue Abbé Cuypers 3 1040 Etterbeek
CompanyCBE no.
2MBT● Active
0745.492.213
3C GROUP● Active
0687.939.539
AB2● Active
0436.055.580
ABH● Active
0438.466.922
AB HOMEMADE● Bankrupt
0663.948.469
ACOLIT● Active
0476.557.040
0540.757.776
ADRA GROUP● Active
1014.780.049
0877.922.947
AKRONOS● Active
0838.112.860
0738.573.143
ALL COMMERCE● Active
0738.499.008
ALPHA 55● Bankrupt
0753.555.584
ANTRASIET● Bankrupt
0884.200.629
0847.212.945
AS DEV STACK● Active
0684.919.869
ASSIMA● Bankrupt
0680.736.003
0461.925.876
Atelier 3● Active
0653.877.790
0479.021.830

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202118/09/2019
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months16 months
Filing date23/06/202625/07/202515/07/202427/11/202330/06/202210/11/2021
General meeting22/06/202625/07/202528/06/202424/11/202313/05/202203/11/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 6 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202522/06/202623/06/2026DutchPDF
Abridged model31/12/202425/07/202525/07/2025DutchPDF
Abridged model31/12/202328/06/202415/07/2024DutchPDF
Abridged model31/12/202224/11/202327/11/2023DutchPDF
Abridged model31/12/202113/05/202230/06/2022DutchPDF
Abridged model31/12/202003/11/202110/11/2021DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

CLV Holding BV

Director · since 21 décembre 2022

Represented by Roel Eduard Jacques Claassen

Active
Geert Vanwalleghem

Director · since 25 septembre 2019

Active

Ended mandates

Marinus Verhofstadt

Director · since 25 novembre 2021 · until 04 mars 2024

Ended
Marinus Verhofstadt

Director · since 25 novembre 2021

Ended
RM Invest BV

Director · until 21 décembre 2022

Represented by Roel Eduard Jacques Claasen

Ended
RM Invest BV

Director

Represented by Roel Eduard Jacques Claasen

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates19/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/07/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/08/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/06/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/10/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other20/09/2019
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202548,6 k €↓
  2. 2024
    Annual accounts 202487,5 k €↑
  3. 2023
    Annual accounts 2023-10,4 k €↓
  4. 2022
    Annual accounts 202256,2 k €↑
  5. 2021
    Annual accounts 202136,3 k €↑
  6. 2020
    Annual accounts 20207,1 k €
  7. 18/09/2019
    IncorporationPrivate limited company